Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

The changes of renin, angiotensin and aldosterone with long term administration of olmesartan:COMPATIBLE extension study

Trial Profile

The changes of renin, angiotensin and aldosterone with long term administration of olmesartan:COMPATIBLE extension study

Completed
Phase of Trial: Phase II

Latest Information Update: 03 Sep 2018

At a glance

  • Drugs Olmesartan medoxomil (Primary)
  • Indications Hypertension
  • Focus Biomarker; Pharmacodynamics
  • Acronyms COMPATIBLE extension RAS study
  • Most Recent Events

    • 28 Aug 2018 Status changed from recruiting to completed.
    • 13 Oct 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top